DRTS Alpha Tau Medical Ltd
Price (delayed)
$2.58
Market cap
$181.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.45
Enterprise value
$180.39M
Highlights
The debt has declined by 6% year-on-year
The company's quick ratio fell by 40% YoY and by 33% QoQ
DRTS's equity is down by 26% YoY and by 10% QoQ
Key stats
What are the main financial stats of DRTS
Market
Valuations
Earnings
Shares outstanding
70.38M
Market cap
$181.58M
Enterprise value
$180.39M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.88
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$36.04M
Net income
-$31.75M
EBIT
-$27.45M
EBITDA
-$26.34M
Free cash flow
-$22.02M
Per share
Balance sheet
Liquidity
EPS
-$0.45
EPS diluted
-$0.45
Free cash flow per share
-$0.31
Book value per share
$0.89
Revenue per share
$0
TBVPS
$1.23
Total assets
$86.2M
Total liabilities
$23.54M
Debt
$12.54M
Equity
$62.67M
Working capital
$55.55M
Debt to equity
0.2
Current ratio
7.4
Quick ratio
6.87
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-33.8%
Return on equity
-44.5%
Return on invested capital
-29.8%
Return on capital employed
-35.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DRTS stock price
How has the Alpha Tau Medical stock price performed over time
Intraday
3.2%
1 week
-1.53%
1 month
-14.57%
1 year
-10.73%
YTD
-16.77%
QTD
2.79%
Financial performance
How have Alpha Tau Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$36.04M
Net income
-$31.75M
Gross margin
N/A
Net margin
N/A
DRTS's net income is down by 9% year-on-year and by 7% since the previous quarter
Growth
What is Alpha Tau Medical's growth rate over time
Valuation
What is Alpha Tau Medical stock price valuation
P/E
N/A
P/B
2.88
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
DRTS's EPS is down by 7% YoY and by 4.7% from the previous quarter
DRTS's equity is down by 26% YoY and by 10% QoQ
DRTS's P/B is 3.3% above its last 4 quarters average of 2.7
Efficiency
How efficient is Alpha Tau Medical business performance
Alpha Tau Medical's return on invested capital has decreased by 43% YoY and by 27% QoQ
DRTS's ROE is down by 39% YoY and by 15% from the previous quarter
The ROA has contracted by 28% YoY and by 13% from the previous quarter
Dividends
What is DRTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DRTS.
Financial health
How did Alpha Tau Medical financials performed over time
The company's quick ratio fell by 40% YoY and by 33% QoQ
The current ratio is down by 39% year-on-year and by 33% since the previous quarter
The debt is 80% smaller than the equity
DRTS's equity is down by 26% YoY and by 10% QoQ
DRTS's debt to equity is up by 25% YoY and by 11% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.